- Drug Pipelines
- December 2019
- 134 Pages
Global
From €3436EUR$3,500USD£2,858GBP
- Drug Pipelines
- November 2019
- 60 Pages
Global
From €3436EUR$3,500USD£2,858GBP
- Drug Pipelines
- November 2018
- 86 Pages
Global
From €3436EUR$3,500USD£2,858GBP
- Drug Pipelines
- June 2018
- 26 Pages
Global
From €3436EUR$3,500USD£2,858GBP
- Report
- April 2022
- 80 Pages
Africa
From €1963EUR$2,000USD£1,633GBP
- Report
- April 2022
- 40 Pages
Brazil
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
China
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
France
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
Germany
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
India
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
Ireland
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
Japan
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
Russia
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
Saudi Arabia
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
South Korea
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
United States
From €1473EUR$1,500USD£1,225GBP
- Report
- April 2022
- 40 Pages
Vietnam
From €1473EUR$1,500USD£1,225GBP
- Report
- March 2022
- 40 Pages
Saudi Arabia
From €1473EUR$1,500USD£1,225GBP
- Report
- March 2022
- 40 Pages
India
From €1473EUR$1,500USD£1,225GBP
- Report
- March 2022
- 100 Pages
Global
From €2454EUR$2,500USD£2,041GBP
The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more